Jieun Kim

Dr. Jieun Kim

Division of Pulmonary and Critical Care Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2024 in Cells
Verified
Journal Article
Open access
PDF file
JKJieun Kim
Jieun Kim
EEEun-Young Eo
Eun-Young Eo
BKBokyong Kim
Bokyong Kim
HLHeetak Lee
Heetak Lee
JKJihoon Kim
Jihoon Kim
YCYoung-Jae Cho
Young-Jae Cho
To develop in vitro respiratory models, it is crucial to identify the factors involved in epithelial cell differentiation. In this study, we comprehensively analyzed the effects of air–liquid interface (ALI) culture on epithelial cell differentiation using single-cell RNA sequencing (scRNA-seq). ALI culture induced a pronounced shift in cell composition, marked by a fivefold increase in ciliated cells and a reduction of more than half in basal cells. Transcriptional signatures associated with epithelial cell differentiation, analyzed using iPathwayGuide software, revealed the downregulation of VEGFA and upregulation of CDKN1A as key signals for epithelial differentiation. Our findings highlight the efficacy of the ALI culture for replicating the human lung airway epithelium and provide valuable insights into the crucial factors that influence human ciliated cell differentiation.

20 November 2025 in Advanced Biology
Verified
Journal Article
Open access
BKBokyong Kim
Bokyong Kim
SKSo‐Hui Kim
So‐Hui Kim
JKJieun Kim
Jieun Kim
EEEun‐Young Eo
Eun‐Young Eo
HKHyung-Jun Kim
Hyung-Jun Kim
YCYoung-Jae Cho
Young-Jae Cho
Acute Respiratory Distress Syndrome (ARDS) is a life‐threatening condition characterized by severe inflammation and lung damage, leading to critical hypoxemia. Despite its high mortality rate, the only currently available treatment, Dexamethasone, is associated with significant side effects. This study aims to evaluate the efficacy of primed human umbilical cord blood‐derived mesenchymal stem cells (hUCB‐pMSCs) as a potential alternative treatment for ARDS. A novel lung microphysiological system (MPS) modeling the lung environment is developed and treated with lipopolysaccharide (LPS) to simulate ARDS. The effects of hUCB‐pMSCs and dexamethasone are compared using state‐of‐the‐art methods, including fluorescence‐based imaging and single‐cell RNA sequencing. The hUCB‐pMSCs significantly activated angiogenesis‐related pathways in endothelial cells and enhanced the formation of tip‐like endothelial cells involved in new blood vessel formation. These findings are corroborated by fluorescence microscopy, demonstrating the robust potential of hUCB‐pMSCs as a therapeutic approach. Overall, the results support the potential of hUCB‐pMSCs as a promising alternative treatment for ARDS.